top of page


News
Categories
Sign up
Featured Posts


Archive


- Nov 26, 2019
Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...


- Jul 17, 2017
Alpha Tau Medical Secures Second Funding Round to Treat Solid Tumors with Alpha Radiation
Following the promising preliminary clinical results, showing the ability of Alpha DaRT to effectively and safely destroy solid tumors,...
bottom of page